<DOC>
	<DOCNO>NCT00716690</DOCNO>
	<brief_summary>The propose research focus development innovative protocol mismatch stem cell transplantation combine 2 different haplo stem cell transplantation ( SCT ) donor mismatch recipient ( preferably ) , patient need SCT , lack HLA match relate unrelated donor . This innovative protocol name multi donor stem cell transplantation ( MDT ) design facilitate engraftment even reduce intensity conditioning low cell dose use , improve graft vs. leukemia ( GVL ) effect enhance immune reconstitution ( use quantitative qualitative parameter ) .</brief_summary>
	<brief_title>Multi Donor Mismatched Stem Cell Transplantation ( MDT )</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Inclusion criterion : 1 . Patient age 070 year old leukemia 1st remission high risk relapse unfavorable prognostic feature , 2nd CR MDS without readily available match donor ( relate unrelated ) . 2 . Patients must mismatch donor willing capable donate peripheral blood stem cell and/or bone marrow progenitor cell use conventional technique , lymphocyte indicate ( mismatch define 3/64/6 HLA matching ) . 3 . Each patient / patient 's guardian must sign write informed consent . 4 . Patients must ECOG PS â‰¤ 2 ; Creatinine &lt; 2.0 mg/dl ; Ejection fraction &gt; 40 % ; DLCO &gt; 50 % predict ; Serum bilirubin &lt; 3 gm/dl ; elevate GPT GOT &lt; 3 x normal value . Exclusion criterion : 1 . Not fulfil inclusion criterion . 2 . Not CR ( indication transplant leukemia ) . 3 . Active lifethreatening infection . 4 . Overt untreated infection . 5 . HIV seropositivity , Hepatitis B C antigen positivity evidence active hepatitis . 6 . Pregnant lactating woman . 7 . Donor contraindication ( HIV seropositive confirm Western Blot , Hepatitis B antigenemia , HCV , evidence bone marrow disease , unable donate bone marrow peripheral blood due concurrent medical condition ) . 8 . Previous autologous allogeneic stem cell transplantation . 9 . Inability comply study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Stem cell transplantation</keyword>
	<keyword>GVHD</keyword>
</DOC>